Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
991 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01171417 | A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer(ACT-FASTER:) | completed | — | 570 | AstraZenecaINDUSTRY | 1 | Feb 27, 2014 | clinicaltrials |
| NCT01144572 | Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment(BC Qol NIS) | completed | — | 494 | AstraZenecaINDUSTRY |
| 1 |
| Feb 14, 2014 |
| clinicaltrials |
| NCT01711502 | Epidemiology and Management of Metastatic Breast Cancer | completed | — | 128 | AstraZenecaINDUSTRY | 1 | Jan 30, 2014 | clinicaltrials |
| NCT01818947 | Gefitinib Usage and Outcomes in Routine Treatment | completed | — | 157 | AstraZenecaINDUSTRY | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00515866 | Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer | completed | Phase 1 | 68 | AstraZenecaINDUSTRY | 2 | Dec 20, 2013 | clinicaltrials |
| NCT00006048 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006049 | ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia(IPASS) | completed | Phase 3 | 1,329 | AstraZenecaINDUSTRY | 9 | Nov 7, 2013 | clinicaltrials |
| NCT01795352 | Retrospective Study in a NSCLC M+ p(Ca_Pulmon) | completed | — | 187 | AstraZenecaINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00997230 | Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m(REASON) | completed | — | 4,243 | AstraZenecaINDUSTRY | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00243347 | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 2 | Oct 17, 2013 | clinicaltrials |
| NCT00536107 | Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 4 | 14 | AstraZenecaINDUSTRY | 1 | Oct 1, 2013 | clinicaltrials |
| NCT01715155 | Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study | completed | — | 171 | AstraZenecaINDUSTRY | 1 | Aug 22, 2013 | clinicaltrials |
| NCT00014690 | ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 2 | — | AstraZenecaINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01112397 | Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours | terminated | Phase 1 | 72 | AstraZenecaINDUSTRY | 1 | Jul 22, 2013 | clinicaltrials |
| NCT01208779 | Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | — | 90 | AstraZenecaINDUSTRY | 1 | Jul 17, 2013 | clinicaltrials |
| NCT01351688 | An Open Label Prostate Cancer Study in Japanese Patients | completed | Phase 1 | 13 | AstraZenecaINDUSTRY | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | completed | Phase 2 | 139 | AstraZenecaINDUSTRY | 8 | May 27, 2013 | clinicaltrials |
| NCT01020604 | PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients(PROTECT-Z) | completed | — | 1,376 | AstraZenecaINDUSTRY | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00314782 | Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 3 | Mar 12, 2013 | clinicaltrials |
| NCT00637039 | Study of AZD8931 in Patients With Advanced Solid Malignancies | completed | Phase 1 | 41 | AstraZenecaINDUSTRY | 2 | Mar 12, 2013 | clinicaltrials |
| NCT01139619 | A Retrospective Study to Investigate the Current Situation of Biopsy Testing in Swedish Inoperable Non Small Cell Lung Cancer (NSCLC) Patients(MAPSY) | completed | — | 136 | AstraZenecaINDUSTRY | 1 | Feb 25, 2013 | clinicaltrials |
| NCT00542594 | Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy(ARIES) | terminated | — | 1,840 | AstraZenecaINDUSTRY | 0 | Feb 7, 2013 | clinicaltrials |
| NCT01102400 | A Study of MEDI-575 in Patients With Advanced Solid Malignancies | completed | Phase 1 | 22 | AstraZenecaINDUSTRY | 1 | Feb 6, 2013 | clinicaltrials |
| NCT00265070 | Trial of Iressa in Prostate Cancer Patients | completed | Phase 2 | 80 | AstraZenecaINDUSTRY | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00562458 | Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer | completed | — | 200 | AstraZenecaINDUSTRY | 0 | Feb 5, 2013 | clinicaltrials |
| NCT00688532 | Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not | completed | — | 5,103 | AstraZenecaINDUSTRY | 0 | Jan 31, 2013 | clinicaltrials |
| NCT00291759 | ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation. | completed | Phase 3 | 3,858 | AstraZenecaINDUSTRY | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00544986 | A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer | completed | Phase 4 | — | AstraZenecaINDUSTRY | 0 | Jan 30, 2013 | clinicaltrials |
| NCT00090675 | Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer(IMAC/Herbst) | withdrawn | Phase 3 | 0 | AstraZenecaINDUSTRY | 0 | Jan 29, 2013 | clinicaltrials |
| NCT00537771 | Liver Safety Under Upfront Arimidex vs Tamoxifen(HEART) | completed | Phase 4 | 384 | AstraZenecaINDUSTRY | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00919477 | Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg(CAMON) | completed | — | 712 | AstraZenecaINDUSTRY | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01116271 | Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec | completed | Phase 2 | 32 | AstraZenecaINDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00090363 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | completed | Phase 2 | 447 | AstraZenecaINDUSTRY | 14 | Jan 8, 2013 | clinicaltrials |
| NCT00034879 | Iressa Expanded Access Program (EAP) | completed | Phase 3 | — | AstraZenecaINDUSTRY | 1 | Jan 4, 2013 | clinicaltrials |
| NCT01284608 | Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)(UROCOR) | completed | — | 197 | AstraZenecaINDUSTRY | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00610714 | AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer(OVERT-1) | completed | Phase 2 | 211 | AstraZenecaINDUSTRY | 12 | Dec 18, 2012 | clinicaltrials |
| NCT00621361 | Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients | completed | Phase 1 | 62 | AstraZenecaINDUSTRY | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01596530 | Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment(CHIVE) | terminated | Phase 1 | 3 | AstraZenecaINDUSTRY | 3 | Dec 17, 2012 | clinicaltrials |
| NCT01330862 | Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA(EPICLIN) | unknown | — | 54 | AstraZenecaINDUSTRY | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01277926 | Patterns of Care in Hormone-receptor Positive, Advanced Breast Cancer | terminated | — | 7 | AstraZenecaINDUSTRY | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00857012 | Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT)(COMPACT) | completed | — | 2,313 | AstraZenecaINDUSTRY | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00306891 | Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™) | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)(HORIZON I) | completed | Phase 2 | 215 | AstraZenecaINDUSTRY | 9 | Oct 24, 2012 | clinicaltrials |
| NCT00608868 | SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients(SELINE) | completed | Phase 4 | 156 | AstraZenecaINDUSTRY | 1 | Sep 28, 2012 | clinicaltrials |
| NCT00836160 | Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy | completed | — | 36 | AstraZenecaINDUSTRY | 1 | Sep 20, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT01167972 | Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma(MUTACT) | completed | — | 2,000 | AstraZenecaINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials